Samuel J. Reich

Insider Reports History

Location
Philadelphia, PA
Signature
/s/ Samuel J. Reich
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel J. Reich:

Company Role Class Num Shares Value Price $ Report Date Ownership
SAB Biotherapeutics, Inc. CEO & EXECUTIVE CHAIRMAN, Director Stock Option (right to buy) 4,800,000 26 Aug 2025 Direct

Insider Reports Filed by Samuel J. Reich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SABS SAB Biotherapeutics, Inc. 26 Aug 2025 1 $0 4 CEO & EXECUTIVE CHAIRMAN, Director 28 Aug 2025, 17:15
SABS SAB Biotherapeutics, Inc. 15 Jul 2024 1 $0 4 CEO & EXECUTIVE CHAIRMAN, Director 17 Jul 2024, 16:30
SABS SAB Biotherapeutics, Inc. 21 Feb 2024 1 $0 4 CEO & EXECUTIVE CHAIRMAN, Director 23 Feb 2024, 16:40
SABS SAB Biotherapeutics, Inc. 29 Nov 2023 1 +$9,842 4 Executive Chairman, Director 30 Nov 2023, 08:00
SABS SAB Biotherapeutics, Inc. 14 Mar 2023 1 $0 4 Executive Chairman, Director 16 Mar 2023, 16:28
SABS SAB Biotherapeutics, Inc. 28 Feb 2023 2 $0 4 Executive Chairman, Director 02 Mar 2023, 08:18
SABS SAB Biotherapeutics, Inc. 13 Sep 2022 1 $0 4 Executive Chairman, Director 15 Sep 2022, 17:15
SABS SAB Biotherapeutics, Inc. 20 May 2022 2 $0 4 Executive Chairman, Director 23 May 2022, 17:45
SABS SAB Biotherapeutics, Inc. 16 Mar 2022 1 $0 4 Executive Chairman, Director 18 Mar 2022, 21:15
SABS SAB Biotherapeutics, Inc. 17 Nov 2021 1 $0 4 Executive Chairman, Director 19 Nov 2021, 15:05
SABS Big Cypress Acquisition Corp. 14 Oct 2021 1 +$10,110 4 CEO and CFO, Director, 10%+ Owner 15 Oct 2021, 10:48